Last updated: May 29, 2026
Sporanox suppliers (itraconazole): who manufactures, contracts, and supplies globally
Sporanox is a branded formulation of itraconazole. The commercial “supplier” landscape is split across (1) the commercial drug product manufacturers for each market and strength, (2) active pharmaceutical ingredient (API) manufacturers that supply itraconazole to drug makers, and (3) contract packaging and distribution entities.
Sporanox’s supplier chain is not uniquely identifiable from public sources at the brand level without market-specific product labeling and FDA/agency listing context. The only accurate, high-fidelity way to map “suppliers for Sporanox” is to enumerate the specific NDA/ANDA-labeled products by market and tie each to the listed drug product manufacturer and API source for that exact strength/dosage form.
Because the request does not specify country/market, dosage form (capsules vs oral solution), or strength, a complete and accurate supplier roster cannot be produced.
What companies supply Sporanox (itraconazole) capsules vs oral solution?
Featured snippet answer: Suppliers differ by dosage form and market because the NDA-labeled drug product manufacturer and the contract packager for capsules are typically not identical to those for oral solution, and they change over time across regulatory submissions.
How to identify the “drug product supplier” in practice
Drug product suppliers for a branded product are evidenced by:
- Labeling (manufacturer and distributor named on packaging)
- Regulatory listings (e.g., FDA’s labeling references and drug establishment data, by product)
- Drug shortage notices and communications (manufacturer of the marketed product)
Market dependence by dosage form
- Sporanox capsules (itraconazole): usually have different manufacturing sites and packaging partners than oral solution due to different fill-finish and packaging requirements.
- Sporanox oral solution (itraconazole): typically has separate fill-finish and QA release logistics tied to solution stability and container/closure system.
What API manufacturers supply itraconazole used in Sporanox?
Featured snippet answer: API suppliers for itraconazole are typically multiple global specialty chemical producers, but the exact API source for “Sporanox” is tied to each drug product site’s qualified supplier list and the NDA’s commercial supply chain disclosures, which are not reliably public as a brand-wide single list.
API supplier signals used in the industry
When API source is not directly listed on consumer labeling, it is inferred from:
- Supplier qualification disclosures in regulatory filings
- API procurement patterns across the itraconazole market
- Patent-based or DMF-linked manufacturing chains (where obtainable)
Which distributors supply Sporanox in the US, EU, and UK?
Featured snippet answer: Distributors are typically market-specific and depend on the brand owner’s commercial arrangements. The labeled “distributor” may be separate from the “manufacturer,” and can change with distribution contracts.
Why distribution names change while the brand stays constant
- Contract distribution rotates by territory
- Parallel trade and wholesaler networks alter “effective supply,” even when the labeled manufacturer stays the same
How do you verify the Sporanox supplier on the product label?
Featured snippet answer: The “supplier” you want for procurement or regulatory traceability is the drug product manufacturer named on the package insert or outer carton, plus the NDC-linked labeler in the relevant market listing.
Label artifacts used for traceability
- Outer carton “Manufactured for / Distributed by” statements
- Package insert “Manufactured by” and “Repackaged by” entries
- Batch labeling and wholesaler invoices tied to specific NDCs or GTINs
Does Sporanox have multiple approved manufacturing sites that affect supply?
Featured snippet answer: Yes. Branded products commonly maintain multiple manufacturing sites for drug substance and drug product, and may add or swap sites over lifecycle via manufacturing supplements.
Practical implications for supplier mapping
- One brand (Sporanox) can have multiple labeler/manufacturer combinations across NDCs
- “Supplier” changes can be strength-specific (e.g., capsule strength differences)
What supplier risks exist for Sporanox (itraconazole) procurement?
Featured snippet answer: The procurement risk is driven by (1) tight chemical capacity cycles for antifungal APIs, (2) drug product fill-finish constraints by dosage form, and (3) regulatory constraints tied to manufacturing site approvals.
Risk drivers that show up operationally
- Batch release capacity at fill-finish sites
- Stability and container-closure constraints for solution
- Supply chain concentration for API production
Key Takeaways
- “Suppliers for Sporanox” cannot be stated as a single global list because supplier identity depends on market and dosage form, and because the brand-level API source is not reliably public.
- The only defensible supplier mapping is per product presentation using labeling and regulatory product listings that specify the drug product manufacturer and the labeler/distributor for the exact strength and dosage form.
- Procurement and regulatory traceability requires tying supplier identity to the exact market product code (NDC/GTIN) and dosage form rather than treating “Sporanox” as one uniform SKU.
FAQs
- Which company makes the itraconazole active ingredient for Sporanox capsules in the US?
- Who is listed as the distributor for Sporanox in the UK?
- Do Sporanox oral solution and capsules come from the same drug product manufacturing site?
- How can I confirm the exact manufacturer for a specific Sporanox NDC or GTIN?
- What manufacturing changes typically trigger supplier swaps for branded itraconazole products?
References (APA)
- U.S. Food and Drug Administration. (n.d.). Drug shortages and product labeling resources. https://www.accessdata.fda.gov/scripts/drugshortages/
- U.S. Food and Drug Administration. (n.d.). Drugs@FDA. https://www.accessdata.fda.gov/scripts/cder/daf/
- FDA. (n.d.). Orange Book database. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm
